Pfizer PFE offers a high dividend yield, making it appealing to income‑focused investors who prioritize steady cash returns over rapid growth. The drugmaker, whose products include antiviral ...

The pharmaceutical company has been investing in its future growth, but whether its efforts will pay off is a big question ...

NEW YORK, N.Y. — Pfizer announced Wednesday that data shows a third dose of its COVID-19 vaccine can “strongly” boost protection against the highly transmissible delta variant. The pharmaceutical and ...

Pfizer Inc. (NYSE:PFE) is one of the best inexpensive stocks to buy now. On January 20, Novavax announced a non-exclusive licensing agreement with Pfizer, granting the pharmaceutical giant access to ...

Pfizer offers a 6.3% yield, but its high dividend reflects weak growth prospects and looming patent cliffs. PFE’s dividend is currently covered by cash flow, but payout ratios are stretched, and ...

Pfizer Inc. and Novo Nordisk A/S boosted their bids for obesity startup Metsera Inc. Novo’s updated offer values Metsera at a total of $10 billion, compared to the offer from Pfizer, which values the ...